ArticleFrontiers in oncology2024

Proteomic and transcriptomic analyses identify apo-transcobalamin-II as a biomarker of overall survival in osteosarcoma.

Ryan A Lacinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.